<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib15">
 <label>15</label>
 <element-citation publication-type="journal" id="sref15">
  <person-group person-group-type="author">
   <name>
    <surname>Couch</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Y.J.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Tarrant</surname>
    <given-names>J.M.</given-names>
   </name>
   <name>
    <surname>Fuji</surname>
    <given-names>R.N.</given-names>
   </name>
   <name>
    <surname>Meilandt</surname>
    <given-names>W.J.</given-names>
   </name>
   <name>
    <surname>Solanoy</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Tong</surname>
    <given-names>R.K.</given-names>
   </name>
   <name>
    <surname>Hoyte</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Luk</surname>
    <given-names>W.</given-names>
   </name>
  </person-group>
  <article-title>Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier</article-title>
  <source>Sci. Transl. Med.</source>
  <volume>5</volume>
  <year>2013</year>
  <fpage>1</fpage>
  <lpage>12</lpage>
  <comment>183ra57</comment>
 </element-citation>
</ref>
